Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021
Katsuhiko Iwakiri, Yasuhiro Fujiwara, Noriaki Manabe, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 4, pp. 267-285
Open Access | Times Cited: 152

Showing 26-50 of 152 citing articles:

Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial
Lihong Gan, Yufan Wang, Shenan Huang, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 342-342
Open Access | Times Cited: 3
Effect of Laryngopharyngeal Reflux and Potassium‐Competitive Acid Blocker (P‐CAB) on the Microbiological Comprise of the Laryngopharynx
Xiaowei Zheng, Zheng Yujin, Ting Chen, et al.
Otolaryngology (2024) Vol. 170, Iss. 5, pp. 1380-1390
Closed Access | Times Cited: 3
LC–MS/MS method for quick detection of vonoprazan fumarate in human plasma: Development, validation and its application to a bioequivalence study
Xinyan Chen, Tao Chen, Yunzhe Huang, et al.
Biomedical Chromatography (2024) Vol. 38, Iss. 6
Closed Access | Times Cited: 3
Esophageal Reflux Hypersensitivity: A Comprehensive Review
Akinari Sawada, Daniel Sifrim, Yasuhiro Fujiwara
Gut and Liver (2023) Vol. 17, Iss. 6, pp. 831-842
Open Access | Times Cited: 8
JP‐1366: A novel and potent potassium‐competitive acid blocker that is effective in the treatment of acid‐related diseases
Jin Mo Ku, Jin Hee Cho, Kangjeon Kim, et al.
Pharmacology Research & Perspectives (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 8
Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
Ryota Niikura, Atsuo Yamada, Yoshihiro Hirata, et al.
Internal Medicine (2018) Vol. 57, Iss. 17, pp. 2443-2450
Open Access | Times Cited: 24
Vonoprazan poses no additional risk of developing Clostridioides difficile infection compared to proton pump inhibitors
Yohei Saruta, Kenta Watanabe, Tsuyotoshi Tsuji, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 6, pp. 940-947
Closed Access | Times Cited: 7
Proteomic analysis of stimulated saliva in gastroesophageal reflux disease patients with and without erosive tooth wear: Observational study
Tatiana Martini, João Víctor Frazão Câmara, Aline Dionízio, et al.
Journal of Dentistry (2023) Vol. 139, pp. 104724-104724
Closed Access | Times Cited: 7
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect
Shupeng Zou, Mengling Ouyang, Qian Cheng, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 44, Iss. 2, pp. 171-183
Closed Access | Times Cited: 7
Efficacy and safety of endoscopic cardia peripheral tissue scar formation (ECSF) for the treatment of refractory gastroesophageal reflux disease: A systematic review with meta-analysis
Chaoyi Shi, GeSang ZhuoMa, Lina Ying, et al.
Medicine (2024) Vol. 103, Iss. 10, pp. e37062-e37062
Open Access | Times Cited: 2
A systematic review with meta‐analysis: Efficacy and safety of potassium‐competitive acid blocker compared with proton pump inhibitor in the maintenance of healed erosive esophagitis
Daniel Martin Simadibrata, Elvira Lesmana, Muhammad Iqbal Adi Pratama, et al.
JGH Open (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 2
Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología
M.A. Valdovinos Díaz, Mercedes Amieva‐Balmori, Ramón Carmona-Sánchez, et al.
Revista de Gastroenterología de México (English Edition) (2024) Vol. 89, Iss. 1, pp. 121-143
Open Access | Times Cited: 2
Potassium-competitive acid blockers and proton-pump inhibitors for healing of erosive esophagitis: a systematic review and network meta-analysis
Yin Liu, Zhifeng Gao, Xiaohua Hou
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 2
Genetic correlation between smoking behavior and gastroesophageal reflux disease: insights from integrative multi-omics data
Zhaoqi Yan, Yifeng Xu, Keke Li, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Etiologic factors for Barrett’s esophagus: toward countermeasures in Asia
Katsunori Iijima
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 8, pp. 407-420
Closed Access | Times Cited: 2
Vonoprazan-associated Clostridioides difficile infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System
Mengling Ouyang, Shupeng Zou, Qian Cheng, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 2
Development of a prediction score for Barrett’s esophagus in Japanese health checkup settings
So Kodama, Kenta Watanabe, Yosuke Shimodaira, et al.
Esophagus (2024) Vol. 21, Iss. 4, pp. 552-562
Closed Access | Times Cited: 2
Heartburn relief with bicarbonate-rich mineral water: results of the randomised, placebo-controlled phase-III trial STOMACH STILL
Joachim Labenz, Maria Anschütz, Jutta Walstab, et al.
BMJ Open Gastroenterology (2023) Vol. 10, Iss. 1, pp. e001048-e001048
Open Access | Times Cited: 6
Patients with gastroesophageal reflux disease (both reflux oesophagitis and non‐erosive reflux disease): Prevalence and severity of erosive tooth wear and saliva properties
Yuichi Kitasako, Tomohide Tanabe, Mai Koeda, et al.
Journal of Oral Rehabilitation (2023) Vol. 51, Iss. 2, pp. 305-312
Open Access | Times Cited: 6
Prevalence, Predictors, and Management of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy: a Multicenter Cohort Study
Ayman El Nakeeb, Hassan Maged Aldossary, Ahmed Zaid, et al.
Obesity Surgery (2022) Vol. 32, Iss. 11, pp. 3541-3550
Closed Access | Times Cited: 10
Long‐term efficacy of antireflux mucosectomy in patients with refractory gastroesophageal reflux disease
Kazuya Sumi, Haruhiro Inoue, Ryohei Ando, et al.
Digestive Endoscopy (2023) Vol. 36, Iss. 3, pp. 305-313
Closed Access | Times Cited: 5
Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
Zhenhua Wang, Ruixiaotong Sun, Yanan Sheng, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 8, pp. 480-480
Open Access | Times Cited: 9
Adverse events of vonoprazan in the treatments of acid-related diseases: a systematic review and meta-analysis
Haiying Gong, Di Han, Sen Liu, et al.
Revista Española de Enfermedades Digestivas (2022)
Open Access | Times Cited: 9
Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis
Sensen Yang, Weishang Deng, Zeyu Xie, et al.
Medicine (2022) Vol. 101, Iss. 47, pp. e31807-e31807
Open Access | Times Cited: 9
Long-term vonoprazan administration causes gastric fundic gland-type hyperplastic polyps and chronic bleeding
Chihiro Goto, Kenichiro Okimoto, Keisuke Matsusaka, et al.
Clinical Journal of Gastroenterology (2022) Vol. 16, Iss. 2, pp. 159-163
Closed Access | Times Cited: 9

Scroll to top